L19IL2 is a medication being studied for its potential to treat skin cancers. It is designed to target and stimulate the immune system to attack cancer cells directly at the site of the tumor. This approach aims to enhance the body’s natural defenses to fight the cancer more effectively.

L19TNF is another medication involved in the study, which works alongside L19IL2. It is intended to target cancer cells and help destroy them by promoting inflammation at the tumor site. This can potentially lead to the reduction or elimination of the tumor.

Basal Cell Carcinoma (BCC) – A common form of skin cancer that arises from the basal cells in the epidermis. It typically appears as a small, shiny bump or nodule on the skin, often in sun-exposed areas like the face and neck. BCC grows slowly and rarely spreads to other parts of the body, but it can cause local damage if not treated. Over time, it may develop into a larger lesion with a pearly or waxy appearance and visible blood vessels.

Cutaneous Squamous Cell Carcinoma (cSCC) – A type of skin cancer that originates from the squamous cells in the outer layer of the skin. It often presents as a rough, scaly patch or a wart-like growth that may crust or bleed. cSCC can develop on any part of the body but is most common in areas frequently exposed to sunlight. If left untreated, it can grow deeper into the skin and potentially spread to other areas.

Merkel Cell Carcinoma (MCC) – A rare and aggressive form of skin cancer that begins in the Merkel cells, which are found at the base of the epidermis. It usually appears as a painless, firm, red or violet nodule on sun-exposed skin, such as the face, neck, or arms. MCC tends to grow quickly and can spread to other parts of the body, including lymph nodes and internal organs.

Keratoacanthoma (KA) – A skin condition that resembles squamous cell carcinoma and typically appears as a dome-shaped nodule with a central crater. It often develops rapidly over a few weeks and is commonly found on sun-exposed areas of the skin. KA may spontaneously regress over time, but due to its similarity to more serious skin cancers, it is often treated as a precaution.

Malignant Adnexal Tumors of the Skin (MATS) – A group of rare skin cancers that originate from the adnexal structures, such as sweat glands and hair follicles. These tumors can vary in appearance and behavior, ranging from slow-growing to more aggressive forms. They often present as nodules or masses on the skin and can occur anywhere on the body.

Tumors from Cutaneous T-cell Lymphoma (CTCL) – A type of lymphoma that primarily affects the skin, originating from T-cells, a type of white blood cell. CTCL often presents as patches, plaques, or tumors on the skin, which may be itchy or painful. The disease can progress slowly, with skin lesions changing in size and appearance over time.

Kaposi’s Sarcoma (KS) – A cancer that forms in the lining of blood and lymph vessels, often associated with a viral infection. It typically appears as red, purple, or brown patches or nodules on the skin or mucous membranes. KS can affect various parts of the body, including the skin, lymph nodes, and internal organs, and may vary in its rate of progression.